STAT+: Pharmalittle: Judge reverses Purdue Pharma bankruptcy plan; FDA eases access restrictions on abortion pills
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is encouraging. We plan to curl up with a couple of library books, hang with our shortest person, and promenade with our official mascot, who is a lucky boy because he has a two-week sleepover with a neighborhood playmate. Of course, this will make for a busy Pharmalot campus. Wish us luck. And what about you? A holiday is beckoning for many, so time to shop before prices rise even further, assuming you can find anything. You could contribute to the greater good and convince some folks to get vaccinated. Or simply plan the future, since that is where you can expect to spend much of your time. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …
Amid the national furor over abortion, the Food and Drug Administration permanently removed a controversial restriction on access to abortion pills by allowing patients to receive the medicine by mail, instead of requiring them to get the pills in person from specially certified providers, STAT explains. The decision means that medication abortion may become more widely available to women who find it difficult to travel to abortion providers. Going forward, any doctor who is certified to prescribe the pill, which is known as mifepristone, can do so online and have it sent by mail, which will allow pregnancies to be terminated at home, even if the U.S. Supreme Court strikes down Roe v. Wade.
Continue to STAT+ to read the full story…
